Richard Lyght
FDA investigator
Appears on 2 documents from 2014 to 2019, mostly at sites in Florida. Most often cites testing and release for distribution (21 CFR 211.165).
- 2
- Documents on file
- 2.0
- Observations per 483
- 2014
- First seen
- 2019
- Most recent
What they cite most
From 4 observations- 21 CFR 211.165Testing and release for distribution1
- 21 CFR 211.192Production record review1
Activity by year
2014: 1, 2019: 1
Where
Florida 1 · South Dakota 1
Often inspects with
Is Richard Lyght coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
2 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2019-07-26 | 483 Aveva Drug Delivery Systems Inc.Jul 26, 2019 · Miramar, Florida | Miramar, Florida | 2 | |
| 2014-09-12 | 483 Medi-Fare Drug and Home Health Center, Inc.Sep 12, 2014 · Blacksburg, South Dakota | Blacksburg, South Dakota | 2 |
About this profile
What does Richard Lyght inspect?
Richard Lyght appears on 2 documents on file covering 2 sites, mostly in Florida.
What do they cite most often?
21 CFR 211.165 (testing and release for distribution), followed by 21 CFR 211.192.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Richard Lyght is dated Jul 26, 2019.